Non-pharmaceutical interventions and the emergence of pathogen variants.

IF 3.3 3区 医学 Q2 EVOLUTIONARY BIOLOGY
Evolution, Medicine, and Public Health Pub Date : 2022-12-19 eCollection Date: 2023-01-01 DOI:10.1093/emph/eoac043
Ben Ashby, Cameron A Smith, Robin N Thompson
{"title":"Non-pharmaceutical interventions and the emergence of pathogen variants.","authors":"Ben Ashby, Cameron A Smith, Robin N Thompson","doi":"10.1093/emph/eoac043","DOIUrl":null,"url":null,"abstract":"<p><p>Non-pharmaceutical interventions (NPIs), such as social distancing and contact tracing, are important public health measures that can reduce pathogen transmission. In addition to playing a crucial role in suppressing transmission, NPIs influence pathogen evolution by mediating mutation supply, restricting the availability of susceptible hosts, and altering the strength of selection for novel variants. Yet it is unclear how NPIs might affect the emergence of novel variants that are able to escape pre-existing immunity (partially or fully), are more transmissible or cause greater mortality. We analyse a stochastic two-strain epidemiological model to determine how the strength and timing of NPIs affect the emergence of variants with similar or contrasting life-history characteristics to the wild type. We show that, while stronger and timelier NPIs generally reduce the likelihood of variant emergence, it is possible for more transmissible variants with high cross-immunity to have a greater probability of emerging at intermediate levels of NPIs. This is because intermediate levels of NPIs allow an epidemic of the wild type that is neither too small (facilitating high mutation supply), nor too large (leaving a large pool of susceptible hosts), to prevent a novel variant from becoming established in the host population. However, since one cannot predict the characteristics of a variant, the best strategy to prevent emergence is likely to be an implementation of strong, timely NPIs.</p>","PeriodicalId":12156,"journal":{"name":"Evolution, Medicine, and Public Health","volume":"11 1","pages":"80-89"},"PeriodicalIF":3.3000,"publicationDate":"2022-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052376/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Evolution, Medicine, and Public Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/emph/eoac043","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"EVOLUTIONARY BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Non-pharmaceutical interventions (NPIs), such as social distancing and contact tracing, are important public health measures that can reduce pathogen transmission. In addition to playing a crucial role in suppressing transmission, NPIs influence pathogen evolution by mediating mutation supply, restricting the availability of susceptible hosts, and altering the strength of selection for novel variants. Yet it is unclear how NPIs might affect the emergence of novel variants that are able to escape pre-existing immunity (partially or fully), are more transmissible or cause greater mortality. We analyse a stochastic two-strain epidemiological model to determine how the strength and timing of NPIs affect the emergence of variants with similar or contrasting life-history characteristics to the wild type. We show that, while stronger and timelier NPIs generally reduce the likelihood of variant emergence, it is possible for more transmissible variants with high cross-immunity to have a greater probability of emerging at intermediate levels of NPIs. This is because intermediate levels of NPIs allow an epidemic of the wild type that is neither too small (facilitating high mutation supply), nor too large (leaving a large pool of susceptible hosts), to prevent a novel variant from becoming established in the host population. However, since one cannot predict the characteristics of a variant, the best strategy to prevent emergence is likely to be an implementation of strong, timely NPIs.

Abstract Image

Abstract Image

Abstract Image

非药物干预和病原体变种的出现。
非药物干预措施(NPIs),如拉开社会距离和追踪接触者,是重要的公共卫生措施,可以减少病原体的传播。除了在抑制传播方面发挥关键作用外,非药物干预措施还通过调节变异供应、限制易感宿主的可用性以及改变对新型变种的选择强度来影响病原体的进化。然而,目前还不清楚NPI会如何影响新型变种的出现,这些变种能够(部分或完全)逃避已有的免疫力,传播性更强或导致更高的死亡率。我们分析了一个随机双菌株流行病学模型,以确定 NPI 的强度和时间如何影响与野生型具有相似或相反生活史特征的变异体的出现。我们的研究表明,虽然较强和较及时的 NPI 通常会降低变异体出现的可能性,但具有较高交叉免疫力的传染性较强的变异体有可能在中等水平的 NPI 下出现的概率更大。这是因为中等水平的 NPIs 可以使野生型的流行范围既不会太小(有利于提供大量变异),也不会太大(留下大量易感宿主),从而阻止新型变异体在宿主群体中建立起来。然而,由于我们无法预测变异体的特征,防止变异体出现的最佳策略可能是实施强有力的、及时的 NPIs。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Evolution, Medicine, and Public Health
Evolution, Medicine, and Public Health Environmental Science-Health, Toxicology and Mutagenesis
CiteScore
5.40
自引率
2.70%
发文量
37
审稿时长
8 weeks
期刊介绍: About the Journal Founded by Stephen Stearns in 2013, Evolution, Medicine, and Public Health is an open access journal that publishes original, rigorous applications of evolutionary science to issues in medicine and public health. It aims to connect evolutionary biology with the health sciences to produce insights that may reduce suffering and save lives. Because evolutionary biology is a basic science that reaches across many disciplines, this journal is open to contributions on a broad range of topics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信